| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |